Drugs Information: Eribulin
Basic Information
|
||
| ID | DDInter666 | |
| Drug Type | small molecule | |
| Molecular Formula | C40H59No11 | |
| Molecular Weight | 729.908 | |
| Description | Eribulin is a microtubule inhibitor used to treat metastatic breast cancer and metastatic or unresectable liposarcoma. | |
| ATC Classification | L01XX41 | |
| IUPAC Name | (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33S,35R,36S)-20-[(2S)-3-Amino-2-Hydroxypropyl]-21-Methoxy-14-Methyl-8,1 | |
| InChI | Inchi=1S/C40H59No11/C1-19-11-24-5-7-28-20(2)12-26(45-28)9-10-40-17-33-36(51-40)37-38(50-33)39(52-40)35-29(49-37)8-6-25(47-35)13-22(42)14-27-31(16-30(46-24)21(19)3)48-32(34(27)44-4)15-23(43)18-41/H19,23-39,43H,2-3,5-18,41H2,1,4H3/T19-,23+,24+,25-,26+,27+,28+,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39+,40+/M1/S1 | |
| InChI Key | UFNVPOGXISZXJD-JBQZKEIOSA-N | |
| Canonical SMILES | [H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2 | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Eribulin
| Severity level | ID | Name | Mechanism | Detail |
|---|